UBS AM’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.3M Buy
791,072
+131,637
+20% +$5.2M 0.01% 868
2025
Q1
$19.9M Buy
659,435
+39,794
+6% +$1.2M 0.01% 968
2024
Q4
$21.7M Buy
619,641
+333,944
+117% +$11.7M 0.01% 913
2024
Q3
$11.4M Sell
285,697
-34,593
-11% -$1.39M ﹤0.01% 1162
2024
Q2
$15.3M Buy
320,290
+133,963
+72% +$6.38M ﹤0.01% 970
2024
Q1
$8.08M Hold
186,327
﹤0.01% 1075
2023
Q4
$9.43M Buy
186,327
+9,213
+5% +$466K ﹤0.01% 1007
2023
Q3
$8.03M Buy
177,114
+381
+0.2% +$17.3K ﹤0.01% 1024
2023
Q2
$6.32M Hold
176,733
﹤0.01% 1131
2023
Q1
$6.32M Buy
176,733
+937
+0.5% +$33.5K ﹤0.01% 1131
2022
Q4
$6.64M Sell
175,796
-103,828
-37% -$3.92M ﹤0.01% 1080
2022
Q3
$12.4M Buy
279,624
+73,835
+36% +$3.27M 0.01% 890
2022
Q2
$7.62M Sell
205,789
-1,117
-0.5% -$41.4K ﹤0.01% 1074
2022
Q1
$7.66M Buy
206,906
+23,154
+13% +$858K ﹤0.01% 1173
2021
Q4
$5.59M Buy
183,752
+3,087
+2% +$93.9K ﹤0.01% 1364
2021
Q3
$6.06M Buy
180,665
+4,324
+2% +$145K ﹤0.01% 1280
2021
Q2
$7.03M Sell
176,341
-228,183
-56% -$9.1M ﹤0.01% 1239
2021
Q1
$18.2M Sell
404,524
-4,987
-1% -$224K 0.01% 884
2020
Q4
$23.2M Buy
409,511
+60,612
+17% +$3.43M 0.01% 811
2020
Q3
$16.6M Buy
348,899
+10,259
+3% +$487K 0.01% 822
2020
Q2
$20M Sell
338,640
-22,092
-6% -$1.3M 0.01% 739
2020
Q1
$17.1M Buy
360,732
+7,186
+2% +$340K 0.01% 718
2019
Q4
$21.4M Buy
353,546
+16,312
+5% +$985K 0.01% 756
2019
Q3
$20.2M Buy
337,234
+1,207
+0.4% +$72.3K 0.01% 764
2019
Q2
$21.6M Buy
336,027
+207,590
+162% +$13.3M 0.02% 739
2019
Q1
$10.4M Buy
128,437
+15,815
+14% +$1.28M 0.01% 924
2018
Q4
$6.09M Buy
112,622
+5,066
+5% +$274K 0.01% 1018
2018
Q3
$5.55M Buy
107,556
+1,264
+1% +$65.2K ﹤0.01% 1116
2018
Q2
$4.43M Sell
106,292
-174,781
-62% -$7.28M ﹤0.01% 1199
2018
Q1
$12.4M Sell
281,073
-5,444
-2% -$240K 0.01% 875
2017
Q4
$14.4M Buy
286,517
+16,323
+6% +$821K 0.01% 823
2017
Q3
$13.7M Buy
270,194
+6,357
+2% +$322K 0.01% 825
2017
Q2
$13.4M Sell
263,837
-54,523
-17% -$2.77M 0.01% 848
2017
Q1
$12.8M Buy
318,360
+10,877
+4% +$437K 0.01% 845
2016
Q4
$14.7M Sell
307,483
-20,388
-6% -$975K 0.02% 776
2016
Q3
$12M Sell
327,871
-142,934
-30% -$5.24M 0.01% 843
2016
Q2
$11M Sell
470,805
-496,401
-51% -$11.6M 0.01% 859
2016
Q1
$39.2M Buy
967,206
+35,210
+4% +$1.43M 0.05% 430
2015
Q4
$57.7M Sell
931,996
-58,266
-6% -$3.61M 0.07% 313
2015
Q3
$40M Buy
990,262
+4,631
+0.5% +$187K 0.04% 440
2015
Q2
$56.7M Buy
985,631
+71,651
+8% +$4.12M 0.05% 374
2015
Q1
$58.2M Buy
913,980
+163,083
+22% +$10.4M 0.06% 382
2014
Q4
$46.4M Sell
750,897
-40,800
-5% -$2.52M 0.04% 438
2014
Q3
$30.7M Buy
791,697
+33,700
+4% +$1.31M 0.03% 570
2014
Q2
$26.1M Buy
757,997
+340,000
+81% +$11.7M 0.03% 606
2014
Q1
$18.1M Buy
417,997
+60,800
+17% +$2.63M 0.02% 689
2013
Q4
$14.2M Buy
357,197
+126,840
+55% +$5.05M 0.02% 728
2013
Q3
$8.65M Buy
230,357
+180,860
+365% +$6.79M 0.01% 843
2013
Q2
$1.33M Buy
+49,497
New +$1.33M ﹤0.01% 1351